6th Annual TIL Therapies Summit

Kongressthemen
Following the watershed approval of Iovances' Lifileucel, all eyes are now on TIL therapies as the up-and-coming major therapeutic avenue for solid tumor treatment.

The 6th Annual TIL Therapies Summit returns to Boston as the only meeting putting the entire spotlight on TIL drug development, giving you an unmissable opportunity to capitalize on the wave of excitement into this field, as the blockbuster potential of harnessing TILs is now realized with the regulatory seal of approval.

Wissenschaftliche Fach-Gesellschaft
Hanson Wade

Anmerkungen
Brochure: https://go.evvnt.com/2439241-3?pid=4832

Speakers: Andrea Aran Garriga, Postdoctoral Researcher, Hospital Clinic Barcelona, Andrew Weinberg, President and Chief Scientific Officer, AgonOx and more.

https://go.evvnt.com/2439241-2?pid=4832

Frau Lara Chick